Home » Topics » Regulatory » Patents

Patents
RSS

Zeneca claims prostaglandin E antagonists

May 31, 1996

Merck Frosst Canada reveals cyclooxygenase type 2 (COX-2) inhibitors

May 31, 1996

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Retinoid antagonists revealed by Eisai

May 31, 1996

New bradykinin antagonists from Sanofi Winthrop

May 31, 1996

Astra reveals analgesic and immunosuppressive agents

May 31, 1996

HMR discloses 5-HT reuptake inhibitors

May 24, 1996

New contraceptives reported by Akzo Nobel

May 24, 1996

Takeda claims antidiabetic and hypolipidemic agents

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...